Toxic fibrillar oligomers of amyloid-β have cross-β structure
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Although amyloid fibers are found in neurodegenerative diseases, evidence points to soluble oligomers of amyloid-forming proteins as the cytotoxic species. Here, we establish that our preparation of toxic amyloid-β 1–42 (Abeta42) fibrillar oligomers (TABFOs) shares with mature amyloid fibrils the cross-β structure, in which adjacent β-sheets adhere by interpenetration of protein side chains. We study the structure and properties of TABFOs by powder X-ray diffraction, EM, circular dichroism, FTIR spectroscopy, chromatography, conformational antibodies, and celluar toxicity. In TABFOs, Abeta42 molecules stack into short protofilaments consisting of pairs of helical β-sheets that wrap around each other to form a superhelix. Wrapping results in a hole along the superhelix axis, providing insight into how Abeta may form pathogenic amyloid pores. Our model is consistent with numerous properties of Abeta42 fibrillar oligomers, including heterogenous size, ability to seed new populations of fibrillar oligomers, and fiber-like morphology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheldrick, G. M. (2008) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767307043930 · Cited by 87,804
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Fourier Transform Infrared Spectroscopic Analysis of Protein Secondary Structures
Kong, J., & Yu, S. (2007) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2007.00320.x · Cited by 3,536
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434 · cited 3×
“(2005) 3D structure of Alzheimer’s amyloid-beta(1-42) fibrils.”
BackgroundStructure of the cross-β spine of amyloid-like fibrils
Nelson, R., Sawaya, M. R., Balbirnie, M., Madsen, A. Ø., Riekel, C., Grothe, R., & Eisenberg, D. (2005) · Nature · doi:10.1038/nature03680 · Cited by 2,202
Self-citation3D structure of Alzheimer's amyloid-β(1–42) fibrils
Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D., & Riek, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506723102 · Cited by 1,996
Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F., & Tycko, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262663499 · Cited by 1,845
Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. Cohen
Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., & Blake, C. C. F. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1348 · Cited by 1,707
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650 · cited 3×
“In the prion conditions, also classed as amyloid diseases (10), small oligomers have also been identified as the toxic species (11).”
BackgroundFolding proteins in fatal ways
Selkoe, D. J. (2003) · Nature · doi:10.1038/nature02264 · Cited by 1,417
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
The Use of Circular Dichroism in the Investigation of Protein Structure and Function
Kelly, S., & Price, N. (2000) · Current Protein & Peptide Science · doi:10.2174/1389203003381315 · Cited by 1,164
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015 · cited 1×
“In our final steps of the preparation of TABFOs, we elute the Tev cleavage product from a reversephase column followed by lyophilization and resuspension in HFIP to disrupt any aggregates (47).”
MethodLi, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972
The protofilament structure of insulin amyloid fibrils
Jiménez, J. L., Nettleton, E. J., Bouchard, M., Robinson, C. V., Dobson, C. M., & Saibil, H. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142459399 · Cited by 834
X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS
EANES, E. D., & GLENNER, G. G. (1968) · Journal of Histochemistry & Cytochemistry · doi:10.1177/16.11.673 · Cited by 823
Structural Classification of Toxic Amyloid Oligomers
Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783 · cited 3×
“Recently, the availability of structure-specific antibodies has provided a means to group oligomers into two broad antigenic categories known as prefibrillar and fibrillar oligomers (12).”
BackgroundKayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., et al. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-18 · Cited by 773
Analyzing protein circular dichroism spectra for accurate secondary structures
Johnson, W. C. (1999) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(19990515)35:3<307::aid-prot4>3.0.co;2-3 · Cited by 638
Kirkitadze, M. D., Bitan, G., & Teplow, D. B. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10328 · Cited by 585
Kirschner, D. A., Abraham, C., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.503 · Cited by 565
Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03407.x · Cited by 559
Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases
Irvine, G. B., El-Agnaf, O. M., Shankar, G. M., & Walsh, D. M. (2008) · Molecular Medicine · doi:10.2119/2007-00100.irvine · Cited by 550
K2D2: Estimation of protein secondary structure from circular dichroism spectra
Perez-Iratxeta, C., & Andrade-Navarro, M. A. (2008) · BMC Structural Biology · doi:10.1186/1472-6807-8-25 · Cited by 470
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
Hoyer, W., Grönwall, C., Jonsson, A., Ståhl, S., & Härd, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711731105 · Cited by 410
Molecular basis for amyloid-β polymorphism
Colletier, J.-P., Laganowsky, A., Landau, M., Zhao, M., Soriaga, A. B., Goldschmidt, L., Flot, D., Cascio, D., Sawaya, M. R., & Eisenberg, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112600108 · Cited by 402
Self-citationThe X-ray interpretation of denaturation and the structure of the seed globulins
Astbury, W. T., Dickinson, S., & Bailey, K. (1935) · Biochemical Journal · doi:10.1042/bj0292351 · Cited by 386
Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering
Sandberg, A., Luheshi, L. M., Söllvander, S., Pereira de Barros, T., Macao, B., Knowles, T. P. J., Biverstål, H., Lendel, C., Ekholm-Petterson, F., Dubnovitsky, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001740107 · Cited by 358
A primer of amyloid nomenclature
Westermark, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S., Frangione, B., Ikeda, S.-I., Masters, C. L., Merlini, G., Saraiva, M. J., & Sipe, J. D. (2007) · Amyloid · doi:10.1080/13506120701460923 · Cited by 357
Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice
Martins, I. C., Kuperstein, I., Wilkinson, H., Maes, E., Vanbrabant, M., Jonckheere, W., Van Gelder, P., Hartmann, D., D'Hooge, R., De Strooper, B., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601953 · Cited by 311
Chirgadze, Y. N., & Nevskaya, N. A. (1976) · Biopolymers · doi:10.1002/bip.1976.360150402 · Cited by 311
The Common Architecture of Cross-β Amyloid
Jahn, T. R., Makin, O. S., Morris, K. L., Marshall, K. E., Tian, P., Sikorski, P., & Serpell, L. C. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.09.039 · Cited by 304
Sambashivan, S., Liu, Y., Sawaya, M. R., Gingery, M., & Eisenberg, D. (2005) · Nature · doi:10.1038/nature03916 · Cited by 239
Self-citationHigh-resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers
Mastrangelo, I. A., Ahmed, M., Sato, T., Liu, W., Wang, C., Hough, P., & Smith, S. O. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.01.042 · Cited by 231
Phosphofructokinase: structure and control
Evans, P. R., Farrants, G. W., & Hudson, P. J. (1981) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1981.0059 · Cited by 189
Zhu, Y. J., Lin, H., & Lal, R. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1244 · Cited by 180
Characterization of the Amyloid Fibril as a Cross- Protein
Bonar, L., Cohen, A. S., & Skinner, M. M. (1969) · Experimental Biology and Medicine · doi:10.3181/00379727-131-34110 · Cited by 177
Finder, V. H., Vodopivec, I., Nitsch, R. M., & Glockshuber, R. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.12.016 · Cited by 168
A β-Helical Antifreeze Protein Isoform with Increased Activity
Leinala, E. K., Davies, P. L., Doucet, D., Tyshenko, M. G., Walker, V. K., & Jia, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205575200 · Cited by 163
Wu, J. W., Breydo, L., Isas, J. M., Lee, J., Kuznetsov, Y. G., Langen, R., & Glabe, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069542 · Cited by 158
Crystal structures of the OmpF porin: function in a colicin translocon
Yamashita, E., Zhalnina, M. V., Zakharov, S. D., Sharma, O., & Cramer, W. A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.137 · Cited by 152
Evidence for Novel β-Sheet Structures in Iowa Mutant β-Amyloid Fibrils
Tycko, R., Sciarretta, K. L., Orgel, J. P. R. O., & Meredith, S. C. (2009) · Biochemistry · doi:10.1021/bi9002666 · Cited by 140
Fourier Deconvolution of the Amide I Raman Band of Proteins as Related to Conformation
Susi, H., & Byler, D. M. (1988) · Applied Spectroscopy · doi:10.1366/0003702884428905 · Cited by 121
β2-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages
Liu, C., Sawaya, M. R., & Eisenberg, D. S. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1948 · Cited by 118
Self-citationCalabrese, B., Shaked, G. M., Tabarean, I. V., Braga, J., Koo, E. H., & Halpain, S. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.02.006 · Cited by 114
Liu, C., Sawaya, M. R., Cheng, P.-N., Zheng, J., Nowick, J. S., & Eisenberg, D. S. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200222n · Cited by 99
Self-citationRunaway domain swapping in amyloid-like fibrils of T7 endonuclease I
Guo, Z., & Eisenberg, D. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602607103 · Cited by 90
Self-citationP4‐316: Stabilization of neurotoxic Alzheimer amyloid‐beta oligomers by protein engineering
Dubnovitsky, A. P., Sandberg, A., Luheshi, L. M., Söllvander, S., de Barros, T. P., Macao, B., Knowles, T. P. J., Biverstål, H., Lendel, C., Pettersson, F. E., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.061 · Cited by 80
Deaths attributable to Alzheimer's disease in the United States.
Ewbank, D. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.1.90 · Cited by 68
Sedimentation Velocity Analysis of Amyloid Oligomers and Fibrils
Mok, Y.-F., & Howlett, G. J. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)13011-6 · Cited by 54
Gantchev, T. G., & Hunting, D. J. (2008) · Journal of Molecular Modeling · doi:10.1007/s00894-008-0296-x · Cited by 50
Cited by
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
Chiti, F., & Dobson, C. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045115 · Cited by 2,629
“The large oligomers with high β-sheet content, such as those described as FOs, APFs, curvilinear PFs and ASPDs, have been found to represent off-pathway species that need to dissociate prior to forming amyloid fibrils (181, 184, 186).”
BackgroundResultInfluentialSelf-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology
Wei, G., Su, Z., Reynolds, N. P., Arosio, P., Hamley, I. W., Gazit, E., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00542j · Cited by 904
Half a century of amyloids: past, present and future
Ke, P. C., Zhou, R., Serpell, L. C., Riek, R., Knowles, T. P. J., Lashuel, H. A., Gazit, E., Hamley, I. W., Davis, T. P., Fändrich, M., et al. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00199a · Cited by 568
Self-citationStructural Studies of Amyloid Proteins at the Molecular Level
Eisenberg, D. S., & Sawaya, M. R. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045104 · Cited by 523
Self-citationThe antimicrobial protection hypothesis of Alzheimer’s disease
Moir, R. D., Lathe, R., & Tanzi, R. E. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3040 · Cited by 456
Metadata
- Authors
- Stroud, J. C., Liu, C., Teng, P. K., & Eisenberg, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-04-30
- Volume
- 109
- Issue
- 20
- Pages
- 7717-7722
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2013780997
- Cited by
- 303
- References
- 52
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.